Aesthetic Injectables – Pipeline Products by Stage of Development 14
Aesthetic Injectables – Pipeline Products by Segment 15
Aesthetic Injectables – Pipeline Products by Territory 16
Aesthetic Injectables – Pipeline Products by Regulatory Path 17
Aesthetic Injectables – Pipeline Products by Estimated Approval Date 18
Aesthetic Injectables – Ongoing Clinical Trials 19
Aesthetic Injectables Companies – Pipeline Products by Stage of Development 20
Aesthetic Injectables – Pipeline Products by Stage of Development 23
Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
ACROFILL – Product Status 26
ACROFILL – Product Description 26
Advanced Aesthetic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 27
Algeness VL – Product Status 27
Algeness VL – Product Description 27
Advanced Aesthetic Technologies Inc – Ongoing Clinical Trials Overview 28
Algeness VL – A Pivotal Clinical Study to Evaluate the Effectiveness and Safety of Algeness VL for the Correction of Moderate to Severe Nasolabial Folds 29
Algeness VL – A Prospective, Multi-center, Randomized, Controlled, Single-blind Study of the Safety and Effectiveness of Algeness DF 3.5% Deep Volumizing Filler to Correct Age-related Volume Deficit in the Mid-face 29
Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 30
BioDermal Filler – Product Status 30
BioDermal Filler – Product Description 30
Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview 31
Alluris – Product Status 31
Alluris – Product Description 31
Skinlumina – Product Status 32
Skinlumina – Product Description 32
SkinTechMD – Product Status 32
SkinTechMD – Product Description 33
Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 34
AAM SubQ Body Filler – Product Status 34
AAM SubQ Body Filler – Product Description 35
ADM Subdermal Body Filler – Product Status 35
ADM Subdermal Body Filler – Product Description 35
Elastagen – Acne Scars – Product Status 35
Elastagen – Acne Scars – Product Description 36
Elastagen – Skin Quality – Product Status 36
Elastagen – Skin Quality – Product Description 36
HA Threads – Product Status 36
HA Threads – Product Description 37
Juvederm – Decolletage – Product Status 37
Juvederm – Decolletage – Product Description 37
Juvederm – Hands – Product Status 37
Juvederm – Hands – Product Description 38
Juvederm – Neck Lines – Product Status 38
Juvederm – Neck Lines – Product Description 38
Juvederm RejuveCross – Deep Wrinkles – Product Status 38
Juvederm RejuveCross – Deep Wrinkles – Product Description 39
Juvederm RejuveCross – Etched Lines Wrinkles – Product Status 39
Juvederm RejuveCross – Etched Lines Wrinkles – Product Description 39
Juvederm RejuveCross Volumize – Cheek Augmentation – Product Status 39
Juvederm RejuveCross Volumize – Cheek Augmentation – Product Description 40
Juvederm Voluma – Nose – Product Status 40
Juvederm Voluma – Nose – Product Description 40
Juvederm Voluma – Temple – Product Status 40
Juvederm Voluma – Temple – Product Description 41
Juvederm Voluma Global – Malar Augmentation – Product Status 41
Juvederm Voluma Global – Malar Augmentation – Product Description 41
rhCollagen Dermal Filler – Product Status 42
rhCollagen Dermal Filler – Product Description 42
rhCollagen Soft Tissue Filler – Product Status 42
rhCollagen Soft Tissue Filler – Product Description 42
Allergan Aesthetics – Ongoing Clinical Trials Overview 43
Juvederm Voluma Global – Malar Augmentation – A Prospective, Multi-center, Randomized, Controlled, Single-blind Study of the Safety and Effectiveness of Algeness DF 3.5% Deep Volumizing Filler to Correct Age-related Volume Deficit in the Mid-face 44
Juvederm Voluma Global – Malar Augmentation – Clinical, Instrumental and Histological Evaluation of the Combined Use of Onabotulinumtoxin A and Hyaluronic Acid Fillers in Patients with Facial Paralysis 44
Juvederm Voluma – Temple – A Multicenter, Evaluator-blinded, Randomized, No-treatment Controlled Study to Evaluate the Safety and Effectiveness of Juvederm Voluma with Lidocaine for Correction of Temple Hollowing in Chinese Population 45
Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
Hyaluronic Acid Facial Filler – Product Status 46
Hyaluronic Acid Facial Filler – Product Description 46
BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
Biological Breast – Product Status 47
Biological Breast – Product Description 47
Hyaluronic Acid Filler – Bio-cartilage Replacement – Product Status 48
Hyaluronic Acid Filler – Bio-cartilage Replacement – Product Description 48
Hyaluronic Acid Filler – Bladder Tissue Repair – Product Status 48
Hyaluronic Acid Filler – Bladder Tissue Repair – Product Description 49
Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview 50
Cytosmile – Product Status 50
Cytosmile – Product Description 50
MTI-12 – Product Status 51
MTI-12 – Product Description 51
MTI-12 – Surgical Repair – Product Status 51
MTI-12 – Surgical Repair – Product Description 52
BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview 53
SGA300 – Product Status 53
SGA300 – Product Description 53
SGA302 – Product Status 54
SGA302 – Product Description 54
Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
BMI4002 – Product Status 55
BMI4002 – Product Description 55
CellPraxis Pipeline Products & Ongoing Clinical Trials Overview 56
Lipage – Product Status 56
Lipage – Product Description 56
Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview 57
Credurance – Product Status 57
Credurance – Product Description 57
Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
Dermal Filler – Product Status 58
Dermal Filler – Product Description 58
Dexlevo Inc Pipeline Products & Ongoing Clinical Trials Overview 59
Gouri – Product Status 59
Gouri – Product Description 59
EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 60
Cellifique – Product Status 60
Cellifique – Product Description 60
Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview 61
ART FILLER FINE LINES – Product Status 61
ART FILLER FINE LINES – Product Description 61
ART FILLER LIPS – Product Status 62
ART FILLER LIPS – Product Description 62
ART FILLER LIPS SOFT – Product Status 62
ART FILLER LIPS SOFT – Product Description 63
ART FILLER UNIVERSAL – Product Status 63
ART FILLER UNIVERSAL – Product Description 63
ART FILLER VOLUME – Product Status 64
ART FILLER VOLUME – Product Description 64
NCTF 135 – Product Status 64
NCTF 135 – Product Description 65
NCTF 135 HA – Product Status 65
NCTF 135 HA – Product Description 65
Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview 66
Prevelle Lift – Product Status 66
Prevelle Lift – Product Description 66
Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview 67
BiOLinkMatrix Gel – Product Status 67
BiOLinkMatrix Gel – Product Description 67
Hyaluronic Acid Dermal Filler – Product Status 68
Hyaluronic Acid Dermal Filler – Product Description 68
Hallura Ltd – Ongoing Clinical Trials Overview 69
BiOLinkMatrix Gel – Prospective, Interventional, Non-randomized, Open Label Study for the Evaluation of the Safety and Performance of an Injectable Hyaluronic Acid Filler 70
Histogen Inc Pipeline Products & Ongoing Clinical Trials Overview 71
HST002 – Product Status 71
HST002 – Product Description 71
Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview 72
The Chaeum Pure No.1 – Product Status 72
The Chaeum Pure No.1 – Product Description 73
The Chaeum Pure No.2 – Product Status 73
The Chaeum Pure No.2 – Product Description 73
The Chaeum Pure No.3 – Product Status 74
The Chaeum Pure No.3 – Product Description 74
The Chaeum Pure No.4 – Product Status 74
The Chaeum Pure No.4 – Product Description 75
The Chaeum Style – Product Status 75
The Chaeum Style – Product Description 75
Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 76
Wrinkle Filler – Product Status 76
Wrinkle Filler – Product Description 76
Juvenis Ltd Pipeline Products & Ongoing Clinical Trials Overview 77
Tenergel – Product Status 77
Tenergel – Product Description 77
Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview 78
Autologous Globin Dermal Filler – Product Status 78
Autologous Globin Dermal Filler – Product Description 78
LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview 79
LR19059 – Product Status 79
LR19059 – Product Description 80
LR19093 – Product Status 80
LR19093 – Product Description 80
LR20008 – Product Status 80
LR20008 – Product Description 81
LR20023 – Product Status 81
LR20023 – Product Description 81
LR20024 – Product Status 82
LR20024 – Product Description 82
YVOIRE Y-Solution 360 – Product Status 82
YVOIRE Y-Solution 360 – Product Description 83
YVOIRE Y-Solution 540 – Product Status 83
YVOIRE Y-Solution 540 – Product Description 83
YVOIRE Y-Solution 720 – Product Status 84
YVOIRE Y-Solution 720 – Product Description 84
LG Chem Ltd – Ongoing Clinical Trials Overview 85
YVOIRE Y-Solution 360 – A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer 86
YVOIRE Y-Solution 360 – A Multicenter, Randomized, Rater-Blinded, No-Treatment Control Design Clinical Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 360 for Lip Augmentation 86
YVOIRE Y-Solution 540 – A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer 87
YVOIRE Y-Solution 540 – A Randomized, Multicenter, Evaluator-blinded, Active-controlled, Parallel-group Design Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 Versus YVOIRE Volume Plus in Nasolabial Folds Injection 87
YVOIRE Y-Solution 720 – A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer 88
YVOIRE Y-Solution 720 – A Multicenter, Randomized, Evaluator-blinded, No-treatment Control Design Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected for Jawline Contouring 88
YVOIRE Y-Solution 720 – A Multicenter, Randomized, Rater-blinded, No-treatment Control Design Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-face 88
LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview 89
Lumina – Product Status 89
Lumina – Product Description 89
LifeSprout Inc – Ongoing Clinical Trials Overview 90
Lumina – A Prospective, Randomized, Controlled, Multi-center Study of the Safety and Effectiveness of Lumina in the Treatment of Nasolabial Folds 91
Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview 92
MT943 – Product Status 92
MT943 – Product Description 92
Neuramis Deep Lidocaine – Product Status 93
Neuramis Deep Lidocaine – Product Description 93
Neuramis Volume Lidocaine – Product Status 93
Neuramis Volume Lidocaine – Product Description 94
Merz North America Inc Pipeline Products & Ongoing Clinical Trials Overview 95
VP1 Lido US – Product Status 95
VP1 Lido US – Product Description 95
Merz North America Inc – Ongoing Clinical Trials Overview 96
VP1 Lido US – A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido US for Volume Augmentation of the Cheek 97
Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview 98
mRDX-02-17 – Product Status 98
mRDX-02-17 – Product Description 98
Moma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 99
Restogel – 131 – Product Status 99
Restogel – 131 – Product Description 99
N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 100
Ceragenin-Infused Dermal Filler – Product Status 100
Ceragenin-Infused Dermal Filler – Product Description 100
Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview 101
AntaRep – Product Status 101
AntaRep – Product Description 101
PB&B SA Pipeline Products & Ongoing Clinical Trials Overview 102
PB&B Facial Volumizer – Product Status 102
PB&B Facial Volumizer – Product Description 102
PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 103
CosmetaLife – Product Status 103
CosmetaLife – Product Description 103
Dermal Filler – Lip – Product Status 104
Dermal Filler – Lip – Product Description 104
Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview 105
GAL1906 – Product Status 105
GAL1906 – Product Description 105
GP0112 – Product Status 106
GP0112 – Product Description 106
Q-Med AB – Ongoing Clinical Trials Overview 107
GAL1906 – A Randomized, Evaluator-blinded, No-treatment Controlled, Multicenter Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area 108
GP0112 – A Randomized, Evaluator-blinded, Parallel Group, Comparator-controlled, Multicenter Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies 109
Revance Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 110
RHA Redensity – Product Status 110
RHA Redensity – Product Description 110
Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 111
Aesthetic Filler – Product Status 111
Aesthetic Filler – Product Description 111
SYB Filler (SF-01) – Product Status 112
SYB Filler (SF-01) – Product Description 112
Samyang Biopharmaceuticals Corp – Ongoing Clinical Trials Overview 113
SYB Filler (SF-01) – A Randomized, Subject and Evaluator-blind, Matched Pairs, Prospective Study to Compare the Safety and Efficacy Between SYB Filler (SF-01) and Ellanse M in the Correction of Nasolabial Folds 114
Sebana Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 115
Dermal Filler – Product Status 115
Dermal Filler – Product Description 115
Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 116
QST Gel – Product Status 116
QST Gel – Product Description 116
Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 117
FreeWink – Product Status 117
FreeWink – Product Description 117
Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 118
Dermal Filler – Product Status 118
Dermal Filler – Product Description 118
SMA-001 – Product Status 119
SMA-001 – Product Description 119
Silk Medical Aesthetics Inc – Ongoing Clinical Trials Overview 120
Dermal Filler – A Feasibility Clinical Trial of All-natural Dermal Filler for Nasolabial Folds 121
Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 122
Atlean – Product Status 122
Atlean – Product Description 122
Ellanse Lidocaine – Product Status 123
Ellanse Lidocaine – Product Description 123
MaiLi – Product Status 123
MaiLi – Product Description 124
Perfectha G – Product Status 124
Perfectha G – Product Description 124
Perfectha Lips – Product Status 125
Perfectha Lips – Product Description 125
Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 126
Silk Protein – Tissue/Dermal Filler – Product Status 126
Silk Protein – Tissue/Dermal Filler – Product Description 126
Sofregen Medical Inc – Ongoing Clinical Trials Overview 127
Silk Protein – Tissue/Dermal Filler – A Feasibility Study to Evaluate Preliminary Safety and Effectiveness of SMI-01 as a Tissue Filler 128
SunMax Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 129
Sunmax FACIALGAIN Collagen Implant With Lidocaine – Product Status 129
Sunmax FACIALGAIN Collagen Implant With Lidocaine – Product Description 129
Sunmax FULLSGEN With Lidocaine – Product Status 130
Sunmax FULLSGEN With Lidocaine – Product Description 130
SunMax Biotechnology Co Ltd – Ongoing Clinical Trials Overview 131
Sunmax FACIALGAIN Collagen Implant With Lidocaine – Evaluation of Collagen Dermal Filler with Lidocaine for the Correction of Nasolabial Folds: A Prospective, Randomized, Active-controlled, Double Blinded, Multicenter Clinical Trial 132
Sunmax FULLSGEN With Lidocaine – Evaluation of Collagen Dermal Filler with Lidocaine for the Correction of Nasolabial Folds: A Prospective, Randomized, Active-controlled, Double Blinded, Multicenter Clinical Trial 133
TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 134
Injectable Dermal Filler – Product Status 134
Injectable Dermal Filler – Product Description 134
Tempo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 135
MAP Tissue Scaffold-Based Dermal Filler – Product Status 135
MAP Tissue Scaffold-Based Dermal Filler – Product Description 135
Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview 136
Teosyal RHA 1 – Product Status 136
Teosyal RHA 1 – Product Description 136
Teoxane SA – Ongoing Clinical Trials Overview 137
Teosyal RHA 1 – A Prospective, Multicentric, Open-labelled, Interventional Study to Assess Skin Beautification by Treating Fine Lines in the Neck, Perioral and Smiling Lines Areas With TEOSYAL RHA 1 138
Teosyal RHA 1 – A Prospective, Single Blind, Single-center Study Evaluating the Histology and Intradermal Implantation of the Teosyal RHA Collection of Fillers 138
Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview 139
PureVoluma – Product Status 139
PureVoluma – Product Description 139
University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 140
Needle Free Injector – Product Status 140
Needle Free Injector – Product Description 140
Glossary 144
